Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
George Kemble | M | 63 | 13 years | |
Merdad Parsey | M | 61 | 14 years | |
Tassos Gianakakos | M | 51 | 11 years | |
David J. Teece | M | 75 |
University of California, Berkeley
| 42 years |
Bruce B. Darling | M | 71 |
University of California, Berkeley
| 44 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Daniel Swisher | M | 61 | 16 years | |
John Curnutte | M | 72 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 11 years |
Qing Huang | M | 62 |
University of California, Berkeley
| 6 years |
Sung Su Han | M | 72 |
University of California, Berkeley
| 12 years |
Irving Mintzer | M | - |
University of California, Berkeley
| 13 years |
Ingrid Boyes | F | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 10 years |
David Stump | M | 74 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 26 years |
Eric Bjerkholt | M | 64 | 13 years | |
G. Kirk Raab | M | 88 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 10 years |
Steven Ketchum | M | 59 | 13 years | |
Carl Perez | M | - |
University of California, Berkeley
| 8 years |
Kamal H. Khayat | M | - |
University of California, Berkeley
| 7 years |
Vishva Dixit | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
Thomas E. Bell | M | 75 |
University of California, Berkeley
| 4 years |
Stanton D. Wong | M | - |
University of California, Berkeley
| 3 years |
Ray Salomon | M | 61 |
University of California, Berkeley
| 7 years |
Stephen Brady | M | 54 | 3 years | |
Pierre Breber | M | 59 |
University of California, Berkeley
| 5 years |
Jackie W. Hoffmann | F | - |
University of California, Berkeley
| 6 years |
Bahram Nour-Omid | M | - |
University of California, Berkeley
| 4 years |
Andreas C. Cangellaris | M | - |
University of California, Berkeley
| 3 years |
Peter Carson | M | - |
University of California, Berkeley
| 8 years |
Michael J. Estrada | M | - |
University of California, Berkeley
| 3 years |
Ori Sasson | M | - |
University of California, Berkeley
| 6 years |
Sean W. O'Dea | M | - | 2 years | |
Steven Chan | M | 52 | 3 years | |
Denelle Waynick | F | 57 | - | |
Adam Rossman | M | 57 |
University of California, Berkeley
| 6 years |
Nat Simons | M | - |
University of California, Berkeley
| 10 years |
Wai Cheung Tong | M | 71 |
University of California, Berkeley
| 3 years |
Joel Caldwell | M | 69 |
University of California, Berkeley
| 6 years |
June Lee | M | 58 | 3 years | |
Marty Monserez | M | - |
Butler University
| 6 years |
Steven Lo | M | 57 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 13 years |
Michelle Corral | F | - | 4 years | |
Wei-Tek Tsai | M | 64 |
University of California, Berkeley
| 5 years |
Jerry Cacia | M | 57 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 28 years |
Sunil Agarwal | M | 54 | 4 years | |
Tami S. Smason | F | - |
University of California, Berkeley
| 8 years |
Larry Nan-lei Wang | M | - |
University of California, Berkeley
| 4 years |
Richard G. Wallace | M | - |
University of California, Berkeley
| 7 years |
Valerie Pierce | F | 61 | 2 years | |
Sarah Hymowitz | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 22 years |
Sosale Shankara Sastry | M | 68 |
University of California, Berkeley
| 3 years |
Charles Homcy | M | 75 | 5 years | |
Weijian Shan | M | 70 |
University of California, Berkeley
| 4 years |
David Nagler | M | 71 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 7 years |
Eric Stonestrom | M | 62 |
University of California, Berkeley
| 6 years |
Paul Hastings | M | 64 |
Axys Pharmaceuticals, Inc.
Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | 2 years |
Wendy Yarno | F | 68 | 3 years | |
Cynthia J. Ladd | F | 68 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 15 years |
Kevin Starr | M | 61 | 6 years | |
Gordon Ringold | M | 73 | 14 years | |
Eric Topol | M | 69 | 2 years | |
Arthur Levinson | M | 73 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 19 years |
Daniel Adelman | M | 66 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 10 years |
James W. Young | M | 79 | 21 years | |
Mark Perry | M | 68 | 8 years | |
James Young | M | 71 | 13 years | |
Daniel Petree | M | 68 |
Axys Pharmaceuticals, Inc.
Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | 6 years |
James Hildebrand Roberts | M | 67 |
University of California, Berkeley
| 5 years |
Peter Y. Tam | M | 60 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.
University of California, Berkeley
| 7 years |
John M. Whiting | M | 69 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 20 years |
Fu Chieh Hsu | M | - |
University of California, Berkeley
| 3 years |
Mary Cranston | F | 76 | 4 years | |
David Meeker | M | 69 | 3 years | |
James A. Wells | M | 73 | 10 years | |
Annette C. North | F | 58 |
Axys Pharmaceuticals, Inc.
Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | 1 years |
Matthew Fust | M | 59 | 12 years | |
Daryl B. Winter | M | 80 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 18 years |
Homer Pearce | M | 71 | 15 years | |
Gregory M. Heywood | M | 59 |
University of California, Berkeley
| 12 years |
Steve Tighe | M | - |
University of California, Berkeley
| 5 years |
Steven Shak | M | 73 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 11 years |
Michael Cima | M | 64 |
University of California, Berkeley
| 8 years |
Kim Popovits | F | 65 | 3 years | |
Lisa Suennen | F | 58 |
University of California, Berkeley
| 5 years |
Peter J. Knudsen | M | 73 |
University of California, Berkeley
| 3 years |
Jim Zipursky | M | - |
University of California, Berkeley
| 4 years |
Hal Craig | M | - |
University of California, Berkeley
| 4 years |
Blue Dunn | M | - |
University of California, Berkeley
| 4 years |
Joseph P. Bartlett | M | 65 |
University of California, Berkeley
| 4 years |
Brian Bershad | M | - |
University of California, Berkeley
| 4 years |
Steve B. Baus | M | 58 |
University of California, Berkeley
| 4 years |
Steven M. Pietkiewicz | M | 63 |
University of California, Berkeley
| 4 years |
Linda D. Kornfeld | F | - |
University of California, Berkeley
| 4 years |
Mark Silverman | M | - |
University of California, Berkeley
| 4 years |
An van Nguyen | M | - |
University of California, Berkeley
| 4 years |
Pierre Saint-Laurent | M | - |
University of California, Berkeley
| 3 years |
Jay Monahan | M | - |
University of California, Berkeley
| 4 years |
Dean Williams | M | - |
University of California, Berkeley
| 4 years |
Mike Lindstrom | M | - |
University of California, Berkeley
| 4 years |
Rachel Glaser | F | 62 |
University of California, Berkeley
| 4 years |
Gamiel Gran | M | - |
University of California, Berkeley
| 4 years |
John Burke | M | - |
University of California, Berkeley
| 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Robert McDowell
- Personal Network